
Neotiv GmbH closes €10m seed financing
In light of the high-profile Phase III Clarity trial results of Esai/Biogen's Alzheimer's protofibril inhibitor lecanemab, early diagnosis of...

Ethris inks €15m deal with Indian Ciplas
The investment is aimed at establishing a long-term strategic partnership until the end of Q1/2023 between Cipla and Ethris for the development of...

CatalYm GmbH raises €50m to push visugromab development
Following a €60m Series B financing in 2020, Martinsried-based CatalYm GmbH announced the closing of a Series C financing round of €50m. The...

Evidence of deliberate climate damage
For decades, some members of the fossil fuel industry tried to convince the public that a causative link between fossil fuel use and climate warming...

Resolve Biosciences secures US$71m in funding
The current Series B financing brings Mohnheim-based Resolve Biosciences’ financing up to a total of more than $100m. The finance round followed the...

EU Health Union ignoring cardiology
While the EU has already presented rules to establish a European Health Data Space (EHDS) and Europe’s Plan against Cancer within its Medicines...

New partnerships push InDevR for Series B financing
Investments into InDevR, Inc. came from New York-based Adjuvant Capital ($4m) and French bioMèrieux SA ($5m), which will enable the commercial...